Detalles de la búsqueda
1.
Measuring Serum Vedolizumab and Vedolizumab Antibodies: Comparison of Commercial Assays with the Vedolizumab Clinical Development Assay.
Ther Drug Monit
; 45(2): 236-244, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36788448
2.
Evaluating Responses to Gluten Challenge: A Randomized, Double-Blind, 2-Dose Gluten Challenge Trial.
Gastroenterology
; 160(3): 720-733.e8, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33130104
3.
TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study.
Gastroenterology
; 161(1): 66-80.e8, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33722583
4.
Decreased circulating CXCR3 + CCR9+T helper cells are associated with elevated levels of their ligands CXCL10 and CCL25 in the salivary gland of patients with Sjögren's syndrome to facilitate their concerted migration.
Scand J Immunol
; 91(3): e12852, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31733111
5.
Safety, tolerability, pharmacokinetics and pharmacodynamics of the anti-CD38 cytolytic antibody TAK-079 in healthy subjects.
Br J Clin Pharmacol
; 86(7): 1314-1325, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32045493
6.
A Reduction in B, T, and Natural Killer Cells Expressing CD38 by TAK-079 Inhibits the Induction and Progression of Collagen-Induced Arthritis in Cynomolgus Monkeys.
J Pharmacol Exp Ther
; 370(2): 182-196, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31085699
7.
Development and validation of a high-parameter mass cytometry workflow to decipher immunomodulatory changes in celiac disease.
Cytometry B Clin Cytom
; 100(1): 92-102, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33452759
8.
The Evolving Landscape of Biomarkers in Celiac Disease: Leading the Way to Clinical Development.
Front Immunol
; 12: 665756, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33897715
9.
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single-Dose and Multiple-Rising-Dose Study of the BTK Inhibitor TAK-020 in Healthy Subjects.
Clin Transl Sci
; 14(3): 820-828, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33650758
10.
Pharmacokinetics and pharmacodynamics of the cytolytic anti-CD38 human monoclonal antibody TAK-079 in monkey - model assisted preparation for the first in human trial.
Pharmacol Res Perspect
; 6(3): e00402, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29864242
11.
Increased CCL25 and T Helper Cells Expressing CCR9 in the Salivary Glands of Patients With Primary Sjögren's Syndrome: Potential New Axis in Lymphoid Neogenesis.
Arthritis Rheumatol
; 69(10): 2038-2051, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28622456
12.
BTNL8, a butyrophilin-like molecule that costimulates the primary immune response.
Mol Immunol
; 56(4): 819-28, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24036152
13.
PDGF-D inhibition by CR002 ameliorates tubulointerstitial fibrosis following experimental glomerulonephritis.
Nephrol Dial Transplant
; 22(5): 1323-31, 2007 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17308324
14.
Inhibition of in vitro and in vivo T cell responses by recombinant human Tim-1 extracellular domain proteins.
Int Immunol
; 18(3): 473-84, 2006 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-16481347
15.
Antagonism of PDGF-D by human antibody CR002 prevents renal scarring in experimental glomerulonephritis.
J Am Soc Nephrol
; 17(4): 1054-62, 2006 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-16510766
Resultados
1 -
15
de 15
1
Próxima >
>>